Research News and Research

RSS

Syntiron grants sanofi pasteur exclusive world-wide license to its human vaccine against MRSA

Syntiron today announced that it has granted sanofi pasteur an exclusive world-wide license to its human vaccine against Staphylococcus aureus. The agreement includes an undisclosed initial licensing fee, milestone payments and royalty payments on future sales of the product. Staphylococcus aureus, or MRSA (pronounced Mer-sa) is an important hospital-acquired infection and is a major cause of illness and death resulting in excess of 18,000 US deaths a year and a half million hospitalizations, creating a significant economic burden of approximately $3.4 billion annually to the American health care system.

16 Dec 2009

BUSM Pulmonary Center awarded $1.4M grant to derive stem cells and lung progenitors from lung disease patients

Boston University School of Medicine's (BUSM) Pulmonary Center has received a two-year $1.4 million grant from the National Heart, Lung, and Blood Institute to derive stem cells and lung progenitors from patients with lung disease.

16 Dec 2009

ACI survey: 48% of Americans oppose the Senate bill

Consumers oppose the current Senate Healthcare legislation by a two-to-one margin. In a nationwide survey conducted by the American Consumer Institute Center for Citizen Research (ACI), 48% of Americans oppose the Senate bill, while 24% support it.

16 Dec 2009

Ivy Foundation awards nearly $10M for new patient-focused brain cancer research projects

Today, the Ben and Catherine Ivy Foundation (Ivy Foundation), announced that it is funding roughly $10 million for four new patient-focused research projects. As with all Ivy Foundation awards, these projects focus on improving the survival and quality of life for people with brain tumors but also specifically address new strategies to improve treatment development.

16 Dec 2009

EMD Serono, Brigham and Women's Hospital collaborate in MS research

EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced a strategic collaboration with Brigham and Women's Hospital in Boston, to advance basic and clinical research in multiple sclerosis (MS), with the goal of generating new and innovative discoveries that advance treatment for people living with this condition. The multi-faceted agreement will run for up to 5 years, with the potential to renew the alliance thereafter. Both parties decided not to disclose financial details.

16 Dec 2009

Keryx Biopharmaceuticals initiates Phase 3 registration clinical trial for perifosine

Æterna Zentaris Inc., a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the initiation, by its partner Keryx Biopharmaceuticals Inc., of a Phase 3 registration clinical trial for perifosine (KRX-0401), the Company's PI3K/Akt pathway inhibitor, in relapsed/refractory multiple myeloma patients.

16 Dec 2009

Xencor's initiation of novel monoclonal antibody human clinical trial triggers milestone payment from Pfizer

Xencor, Inc., a company using Fc engineering for the discovery and development of next-generation antibodies, announced today that the Company received a milestone payment from Pfizer Inc. The amount of the payment was not disclosed. The payment was triggered by the initiation of human clinical trials of a novel monoclonal antibody therapeutic that was optimized using Xencor technologies under a March 2009 technology license agreement.

16 Dec 2009

Encouraging early clinical results for treatment of KC with Avedro's Keraflex KXL technology

During the 5th International Congress of Corneal Cross Linking for Keratoconus in Leipzig, Germany on December 5th, Avedro presented encouraging early clinical results for treating keratoconus, a progressive disease of the cornea of the eye. The procedure, known as Keraflex® KXL, is non-incisional and reshapes the cornea without removing any tissue.

16 Dec 2009

Reprints Desk signs distribution deals with seven STM journal publishers

Derycz Scientific, Inc., a company that is pioneering a fresh way of facilitating the flow of information from content publishers to enterprise customers and their constituents, today announced that wholly-owned subsidiary Reprints Desk, Inc. has signed distribution deals with seven additional scientific, technical and medical (STM) journal publishers, expanding the pay-per-view content available to Reprints Desk customers and enhancing the speed of delivery.

16 Dec 2009

Pomegranate rind, metal salts and Vitamin C: An effective combination for treating MRSA infection

Pomegranates have already been hailed as a super-food but a team of scientists from Kingston University in South West London has found a new use for the deep red fruit. The team, led by Professor Declan Naughton, has discovered that the rind can be turned into an ointment for treating MRSA and other common hospital infections.

16 Dec 2009

Roche's P2X3 receptor program for chronic pain licensed to Afferent Pharmaceuticals

Roche announced today it has licensed its P2X3 receptor program aimed at developing first-in-class treatments for chronic pain to Afferent Pharmaceuticals. Afferent was co-founded by Anthony Ford, Ph.D., Pappas Ventures, and Third Rock Ventures, and is focused on developing compounds that treat chronic pain by targeting a novel biological pathway.

16 Dec 2009

HHS to provide H1N1 response update on December 17, 2009

U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius and senior HHS officials leading the H1N1 response at the Department will hold a press conference, at the National Press Club on Thursday, December 17, 2009.

16 Dec 2009

New research building at Children's Hospital of Philadelphia receives LEED certification

Building materials that better retain heat in the winter, and reflect it in the summer; plumbing fixtures that save water; and facilities that encourage employees to bicycle to work. Environmentally-friendly features like these enable the new research building at The Children's Hospital of Philadelphia to be certified as a green structure.

16 Dec 2009

Cancer Research UK's phase I trial results of CHT25 published in Clinical Cancer Research

TWO THIRDS of Hodgkin's lymphoma patients treated with an experimental radioactive cancer therapy responded well to the treatment, reveal the results of a Cancer Research UK phase I trial published in Clinical Cancer Research, today (Tuesday).

16 Dec 2009

DNA reveals earliest proven case of leprosy, Turin Shroud not from Jesus-era Jerusalem

The DNA of a 1st century shrouded man found in a tomb on the edge of the Old City of Jerusalem has revealed the earliest proven case of leprosy. Details of the research will be published December 16 in the PloS ONE Journal.

16 Dec 2009

EU border security market boosted by unauthorised immigration and illegal drug trafficking

European Union (EU) member states are spending more on protecting their borders, which are increasingly subjected to unauthorised immigration and illegal drug trafficking. High investment in advanced technology security and IT-based systems will boost the border security market.

16 Dec 2009

Academics and drug companies must work together to win funds for scientific research, says research director

Academics and drug companies must forge more productive relationships in the face of pressure from politicians and funders for more applied biomedical research, a research director has warned.

16 Dec 2009

Challenges U.S. and U.K. cancer patients face in gaining access to expensive treatments

Cancer patients in both the United States and the United Kingdom face challenges in gaining access to expensive treatments, according to research published in the December issue of The Milbank Quarterly.

16 Dec 2009

H1N1 outbreak reveals existing gaps in nation's public health emergency preparedness

The seventh annual Ready or Not? Protecting the Public's Health from Diseases, Disasters, and Bioterrorism report, released today by the Trust for America's Health (TFAH) and the Robert Wood Johnson Foundation (RWJF), found that the H1N1 flu outbreak has exposed serious underlying gaps in the nation's ability to respond to public health emergencies and that the economic crisis is straining an already fragile public health system.

16 Dec 2009

Genes work together by huddling in clusters inside nucleus, research reveals

Research from the Babraham Institute has revealed for the first time that genes work together by huddling in clusters inside the nucleus - the information centre of a cell. These findings, published in the online edition of the journal Nature Genetics, represent a paradigm shift in our understanding of how the genome is spatially organised in relation to gene expression.

16 Dec 2009

Research News and Research

Syntiron grants sanofi pasteur exclusive world-wide license to its human vaccine against MRSA

BUSM Pulmonary Center awarded $1.4M grant to derive stem cells and lung progenitors from lung disease patients

ACI survey: 48% of Americans oppose the Senate bill

Ivy Foundation awards nearly $10M for new patient-focused brain cancer research projects

EMD Serono, Brigham and Women's Hospital collaborate in MS research

Keryx Biopharmaceuticals initiates Phase 3 registration clinical trial for perifosine

Xencor's initiation of novel monoclonal antibody human clinical trial triggers milestone payment from Pfizer

Encouraging early clinical results for treatment of KC with Avedro's Keraflex KXL technology

Reprints Desk signs distribution deals with seven STM journal publishers

Pomegranate rind, metal salts and Vitamin C: An effective combination for treating MRSA infection

Roche's P2X3 receptor program for chronic pain licensed to Afferent Pharmaceuticals

HHS to provide H1N1 response update on December 17, 2009

New research building at Children's Hospital of Philadelphia receives LEED certification

Cancer Research UK's phase I trial results of CHT25 published in Clinical Cancer Research

DNA reveals earliest proven case of leprosy, Turin Shroud not from Jesus-era Jerusalem

EU border security market boosted by unauthorised immigration and illegal drug trafficking

Academics and drug companies must work together to win funds for scientific research, says research director

Challenges U.S. and U.K. cancer patients face in gaining access to expensive treatments

H1N1 outbreak reveals existing gaps in nation's public health emergency preparedness

Genes work together by huddling in clusters inside nucleus, research reveals

A guide to advancing biotherapeutic research eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest Life Science News